<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fourty two children with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) treated in seven centres of The Polish Paediatric <z:mpath ids='MPATH_336'>Leukaemia</z:mpath>/<z:hpo ids='HP_0002665'>Lymphoma</z:hpo> Study Group in period 1975-1998 were included in the study </plain></SENT>
<SENT sid="1" pm="."><plain>In 16 children <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>, in 3 CMML, in 10 RA and in 13 RAEB were diagnosed </plain></SENT>
<SENT sid="2" pm="."><plain>BMT is the best therapy for children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>For children, who have not a donor for BMT, Roacutan therapy seems to be the most effective </plain></SENT>
</text></document>